Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Syzygium jambos genome sequencing and assembly

PROVIDER: PRJNA962713 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR24331300_1.fastq.gz	Fastqsanger.gz
	SRR24331300_2.fastq.gz	Fastqsanger.gz
	SRR24331301_1.fastq.gz	Fastqsanger.gz
	SRR24331301_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 55

Similar Datasets

Project description:Syzygium luehmannii genome assembly

| PRJNA1099473 | ENA

Project description:Syzygium aqueum genome sequencing and assembly

| PRJNA962711 | ENA

Project description:Syzygium malaccense genome sequencing and assembly

| PRJNA962868 | ENA

Syzygium jambos

Project description:Syzygium jambos Genome sequencing and assembly

| PRJNA644417 | ENA

Syzygium aromaticum

Project description:Syzygium aromaticum Genome sequencing and assembly

| PRJNA814411 | ENA

Project description:Syzygium syzygioides genome sequencing and assembly

| PRJNA962712 | ENA

Syzygium aromaticum

Project description:Syzygium aromaticum Genome sequencing and assembly

| PRJNA778325 | ENA

Project description:Syzygium cinereum, Syzygium cumini, and Syzygium grande, complete chloroplast genome

| PRJNA1127591 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Syzygium aromaticum isolate:JA318A

Project description:Syzygium aromaticum isolate:JA318A Genome sequencing and assembly

| PRJNA660399 | ENA